Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

A look at some of the Health Report correspondence this week.   You can email us at healthreport@abc.net.au ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on TG Therapeutics (TGTX – Research Report) today and set a price target ...

While the risks associated with COVID-19 generally have decreased over time due to prior exposure to the vaccines and the virus, some people remain at elevated risk, such as the elderly and ...

By Ava Gonzalez/UW News Lab Despite the current low totals of COVID-19 and flu cases, health officials are warning against complacency as Seattle approaches peak respiratory virus season and a 7 ...

Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

In the closing of the recent trading day, Novavax (NVAX) stood at $10, denoting a -1.19% change from the preceding trading day.

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk ...